Enzon Pharmaceuticals (ENZN) Trading Up In Pre-Market After FDA Approved Its Drug For Rheumatoid Arthritis
Tweet Send to a Friend
Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) is trading up 2.5% in the pre-market after it announced that the FDA approved Cimzia ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
